Recent Blog Articles

Harvard Health Blog

Early, tight control of Crohn’s disease may have lasting benefits

October 16, 2020


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.


October 16, 2020

“Concerns about side effects and the need for frequent monitoring are paramount among the roadblocks.” There should be concern for long term effects as well, there is some evidence for linking of long term use of Remicade with cervical cancer. Patients need all available evidence and information to make an informed decision.

Commenting has been closed for this post.

You might also be interested in…

Ulcerative colitis and Crohn’s disease

Inflammatory bowel disease (IBD) includes a number of conditions in which the immune system mistakenly attacks the intestines and triggers inflammation of the tissues. There are two main kinds of IBD: ulcerative colitis (UC) and Crohn’s disease. Today many medications are available to successfully treat IBD. These therapies work to calm inflammation, reduce and even alleviate symptoms, decrease flare-ups, and help you better cope with your condition. This report provides insight into the possible causes and complications of IBD, how you are diagnosed, and the steps you can take for better care so you can live your best life.

Read More